ABIVAX announced the enrolment of the first patient in the ABX464-101 proof-of-concept study of its lead product candidate ABX464 in...
Read more
Novartis announced that the EC approved Tasigna® (nilotinib) for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic...
Read more
Wellthy Therapeutics a digital therapeutics company that uses artificial intelligence (AI) and patient centric design to improve patient outcomes is...
Read more
WebflowTM is a comprehensive customer support center which provides PCI clients real-time, 24/7 access to a wide range of reports...
Read more
AstraZeneca announced that the US FDA has approved a new indication for Faslodex (fulvestrant), expanding the indication to include use...
Read more
TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer,...
Read more
New data presented showed that Jardiance® reduced the risk of cardiovascular death compared with placebo when added to standard of...
Read more
Boehringer Ingelheim and MiNA Therapeutics (“MiNA”), a pioneer in RNA activation therapeutics, announced that they have signed a collaboration and...
Read more
Median Technologies, The Imaging Phenomics Company® (ALMDT:PA) is pleased to announce that James Golando, Chief of Operations at Median Technologies...
Read more
Sandoz, a Novartis division and the global leader in biosimilars, announces results from the EQUIRA study. The phase III comparative...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
